SCHEMBL23902854

SCHEMBL23902854

O=c1c2cc3c(cc2oc2nc4ccccc4n12)c1ccccc1n3-c1ccc2c(c1)c1ccccc1n2-c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.54
NPC1 O15118 3/20 0.54
KDM4E B2RXH2 4/20 0.38
ATM Q13315 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
MEN1 O00255 7/20 0.35
KMT2A Q03164 7/20 0.35
ALDH1A1 P00352 5/20 0.35
CRHBP P24387 2/20 0.35
CRHR2 Q13324 2/20 0.35
RECQL P46063 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
POLB P06746 3/20 0.35
HSD17B10 Q99714 3/20 0.35
TSHR P16473 1/20 0.35
BRCA1 P38398 1/20 0.35
LMNA P02545 3/20 0.33
GAA P10253 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
MAPT P10636 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25500523 0.96 RAB9A (0.58) RAB9ANPC1KDM4EATML3MBTL1
SCHEMBL23902875 0.91 RAB9A (0.58) RAB9ANPC1KDM4EATML3MBTL1
SCHEMBL23903030 0.88 NPC1 (0.54) RAB9ANPC1KDM4EATML3MBTL1
SCHEMBL26228154 0.86 NPC1 (0.55) RAB9ANPC1KDM4EATML3MBTL1
SCHEMBL23903103 0.85 NPC1 (0.54) RAB9ANPC1KDM4EATML3MBTL1
SCHEMBL23903216 0.82 NPC1 (0.48) RAB9ANPC1KDM4EATML3MBTL1
SCHEMBL23903038 0.82 NPC1 (0.53) RAB9ANPC1KDM4EL3MBTL1MEN1
SCHEMBL23903208 0.81 NPC1 (0.58) RAB9ANPC1KDM4EATML3MBTL1
SCHEMBL23903029 0.80 RAB9A (0.52) RAB9ANPC1KDM4EATML3MBTL1
SCHEMBL26228146 0.80 NPC1 (0.55) RAB9ANPC1KDM4EATML3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230151026-A1 MULTI-LAYER BODY FOR DIFFUSE TRANSILLUMINATION MERCK PATENT GMBH (DE) 2023-05-18 US disclosed
US-20230151026-A1 MULTI-LAYER BODY FOR DIFFUSE TRANSILLUMINATION MERCK PATENT GMBH (DE) 2023-05-18 US disclosed
WO-2021198213-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2021-10-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230151026-A1 MULTI-LAYER BODY FOR DIFFUSE TRANSILLUMINATION DDT, EPCAM, SLC18A3 RAB9A 1937/4885NPC1 1782/4885KDM4E 3347/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.